Judith J Stephenson

Summary

Affiliation: Health Outcomes Research
Country: USA

Publications

  1. pmc Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study
    Judith J Stephenson
    HealthCore Inc, Wilmington, DE 19801, USA
    Health Qual Life Outcomes 10:155. 2012
  2. pmc Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians' perceptions of adherence vs. pharmacy claims
    J J Stephenson
    HealthCore, Inc, Wilmington, DE, USA
    Int J Clin Pract 66:565-73. 2012
  3. ncbi request reprint Subacute lack of asthma control as a predictor of subsequent acute asthma exacerbation in a managed care population
    Judith J Stephenson
    HealthCore, Inc, 800 Delaware Ave, 5th Fl, Wilmington, DE 19801 1366, USA
    Am J Manag Care 16:108-14. 2010
  4. doi request reprint Knee-attributable medical costs and risk of re-surgery among patients utilizing non-surgical treatment options for knee arthrofibrosis in a managed care population
    Judith J Stephenson
    HealthCore, Inc, Wilmington, Delaware 19801 1366, USA
    Curr Med Res Opin 26:1109-18. 2010
  5. doi request reprint Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US
    Judith J Stephenson
    HealthCore, Inc, Wilmington, DE 19801, USA
    Curr Med Res Opin 27:1079-87. 2011
  6. doi request reprint Economic impact of tobramycin in patients with cystic fibrosis in a managed care population
    Debra A Wertz
    HealthCore, Inc, Wilmington, DE 19801, USA
    J Med Econ 14:759-68. 2011
  7. ncbi request reprint Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey
    Siddhesh A Kamat
    1 HealthCore Inc, Wilmington, Delaware, USA 2 Biogen Idec, Cambridge, Massachusetts, USA
    Patient 2:105-12. 2009
  8. doi request reprint Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population
    Qian Cai
    HealthCore, Inc, Wilmington, DE, USA
    J Med Econ 17:148-58. 2014
  9. doi request reprint Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Hiangkiat Tan
    HealthCore, Inc, 800 Delaware Ave, Wilmington, DE 19801, USA
    Adv Ther 28:51-61. 2011
  10. ncbi request reprint Healthcare utilization and costs of patients with rosacea in an insured population
    Michael Romanowicz
    Managed Care and Professional Affairs, CollaGenex Pharmaceuticals, Inc, Newtown, PA 18940, USA
    J Drugs Dermatol 7:41-9. 2008

Detail Information

Publications10

  1. pmc Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study
    Judith J Stephenson
    HealthCore Inc, Wilmington, DE 19801, USA
    Health Qual Life Outcomes 10:155. 2012
    ..We investigated the impact of natalizumab on patient-reported outcomes (PROs) in a real-world setting...
  2. pmc Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians' perceptions of adherence vs. pharmacy claims
    J J Stephenson
    HealthCore, Inc, Wilmington, DE, USA
    Int J Clin Pract 66:565-73. 2012
    ..To compare physician-reported adherence of specific patients to oral second-generation antipsychotics vs. actual adherence rates determined from the patients' pharmacy claims...
  3. ncbi request reprint Subacute lack of asthma control as a predictor of subsequent acute asthma exacerbation in a managed care population
    Judith J Stephenson
    HealthCore, Inc, 800 Delaware Ave, 5th Fl, Wilmington, DE 19801 1366, USA
    Am J Manag Care 16:108-14. 2010
    ..To evaluate whether an assessment of subacute lack of asthma control (SALAC) predicts subsequent acute asthma exacerbation (AAE)...
  4. doi request reprint Knee-attributable medical costs and risk of re-surgery among patients utilizing non-surgical treatment options for knee arthrofibrosis in a managed care population
    Judith J Stephenson
    HealthCore, Inc, Wilmington, Delaware 19801 1366, USA
    Curr Med Res Opin 26:1109-18. 2010
    ....
  5. doi request reprint Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US
    Judith J Stephenson
    HealthCore, Inc, Wilmington, DE 19801, USA
    Curr Med Res Opin 27:1079-87. 2011
    ..This study evaluated the risk of adverse outcomes (AOs), defined as death or recurrent ACS, after clopidogrel discontinuation in a managed-care population...
  6. doi request reprint Economic impact of tobramycin in patients with cystic fibrosis in a managed care population
    Debra A Wertz
    HealthCore, Inc, Wilmington, DE 19801, USA
    J Med Econ 14:759-68. 2011
    ..This study evaluated the economic impact of TSI in managed care CF patients...
  7. ncbi request reprint Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey
    Siddhesh A Kamat
    1 HealthCore Inc, Wilmington, Delaware, USA 2 Biogen Idec, Cambridge, Massachusetts, USA
    Patient 2:105-12. 2009
    ..To assess multiple sclerosis (MS) patients' experience with natalizumab (TYSABRI, Biogen Idec, Inc. and Elan Pharmaceuticals, Inc.) in a clinical practice setting...
  8. doi request reprint Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population
    Qian Cai
    HealthCore, Inc, Wilmington, DE, USA
    J Med Econ 17:148-58. 2014
    ..To evaluate total annual all-cause, gastrointestinal-related, and symptom-related healthcare costs among chronic constipation (CC) patients and estimate incremental all-cause healthcare costs of CC patients relative to matched controls...
  9. doi request reprint Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Hiangkiat Tan
    HealthCore, Inc, 800 Delaware Ave, Wilmington, DE 19801, USA
    Adv Ther 28:51-61. 2011
    ..However, only limited data currently exist on the impact of treatment adherence on MS-related clinical and economic outcomes in the real world setting...
  10. ncbi request reprint Healthcare utilization and costs of patients with rosacea in an insured population
    Michael Romanowicz
    Managed Care and Professional Affairs, CollaGenex Pharmaceuticals, Inc, Newtown, PA 18940, USA
    J Drugs Dermatol 7:41-9. 2008
    ..S. However, there is little data in the literature on the healthcare utilization and costs of patients with rosacea in insured populations...